Vensica Featured in Israel21c

Now there’s needle-free Botox for your bladder

Israeli startups are treating overactive bladder with a range of innovations from Botox to matchstick-sized implants.

By Abigail Klein Leichman, Israel21c (5 September 2016)

Vensica Medical's Vensicare system

VensiCare is the needle-free, painless procedure to deliver Botox® to the bladder wall in the treatment of overactive bladder.

About 66 million Europeans and 43 million Americans suffer from overactive bladder (OAB), which causes sudden, involuntary contractions of the muscle in the wall of the urinary bladder.

ISRAEL21c takes a look at three Israeli companies developing tomorrow’s non-narcotic solutions for OAB.


The Israeli startup Vensica is developing an ultrasound-based catheter that delivers Botox into the bladder wall painlessly, without needles.

Avner Geva founded Vensica in August 2014 in the Trendlines Medical incubator in northern Israel, based on his studies on therapeutic ultrasound and work experience in the Israeli medical device space. In July, the company closed a $500,000 financing round from a private foreign investor.

“I knew ultrasound’s advantages for drug delivery and applied it to the bladder,” he tells ISRAEL21c. “Our main strength is delivery of large molecules such as Botox, and it has to be delivered deeply into the bladder wall. Ultrasound can do this.”


“We hope to begin selling in Europe by the beginning of 2019,” Geva says.

Read the full article on Israel21c.

Leave a Reply

  • Welcome to Trendlines

    We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >

  • Categories

  • Subscribe to Our Newsletter

  • Stay in Touch

    icon-facebook Like us on Facebook

    icon-Twitter Follow us on Twitter

    icon-Linkedin Connect with us on Linkedin

    YouTube-color See us on YouTube

    flipboard  Read us on Flipboard

    google+_icon Join us on Google+

Font Resize